Free Light Chain Assay

This is a blood test used to measure the levels of free kappa and lambda light chains, which are components of antibodies produced by plasma cells. Normally, light chains are bound to heavy chains, but a small amount circulates freely in the bloodstream.

Abnormal levels of these free light chains, or an abnormal kappa/lambda ratio, may indicate plasma cell disorders such as multiple myeloma, light chain amyloidosis, or other related conditions.

The purpose of this test is to:

• Measure free kappa and lambda light chains in the blood
• Evaluate the kappa/lambda ratio
• Diagnose plasma cell disorders such as multiple myeloma
• Detect light chain amyloidosis and related conditions
• Monitor disease progression and treatment response

FREE LIGHT CHAIN ASSAY Test

The Free Light Chain Assay (FLC Assay) measures the levels of free kappa and free lambda light chains in the blood, along with the kappa/lambda ratio. Light chains are components of antibodies produced by plasma cells. Normally, small amounts of unbound light chains circulate in the blood.

The test is primarily used to help detect and monitor plasma cell disorders, including multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), AL amyloidosis, and other related conditions. It can be particularly helpful in conditions where abnormal plasma cells produce excessive amounts of one type of light chain.

The results are generally interpreted by looking at both kappa and lambda concentrations and their ratio. The assay is often performed along with serum protein electrophoresis (SPEP) and immunofixation for a more complete evaluation. Kidney disease can also affect free light-chain levels, so an abnormal result does not automatically mean a plasma cell disorder is present.

This Test is Recommended for Individuals:

• Individuals being evaluated for multiple myeloma
• People with suspected light-chain multiple myeloma
• Individuals being evaluated for AL amyloidosis
• Patients with suspected or known MGUS
• People with unexplained anemia, bone pain, fractures, or kidney problems
• Individuals with abnormal serum protein electrophoresis or immunofixation results
• Patients with suspected monoclonal gammopathy or plasma cell disorders
• Individuals undergoing monitoring of an established plasma cell disorder
• Patients whose healthcare provider recommends evaluation of kappa/lambda light-chain production

FAQs

1. What does the Free Light Chain Assay measure?
It measures the amounts of free kappa and free lambda light chains in the blood and calculates the kappa/lambda ratio. This helps identify an abnormal pattern of light-chain production.

2. Does an abnormal Free Light Chain result mean I have multiple myeloma?
Not necessarily. Abnormal levels can occur with plasma cell disorders as well as kidney disease and some inflammatory or immune conditions. The result needs to be interpreted together with the kappa/lambda ratio, symptoms, medical history, and other laboratory investigations.

3. Is fasting required for the Free Light Chain Assay?
Generally, no special preparation or fasting is required for the test. However, follow any specific instructions given by your healthcare provider or diagnostic laboratory.